• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚叶酸钙解救疗法对儿童急性淋巴细胞白血病治疗中氨甲喋呤诱导的口腔黏膜炎的作用:系统评价。

The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.

机构信息

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

出版信息

Crit Rev Oncol Hematol. 2019 Oct;142:1-8. doi: 10.1016/j.critrevonc.2019.07.003. Epub 2019 Jul 9.

DOI:10.1016/j.critrevonc.2019.07.003
PMID:31323533
Abstract

INTRODUCTION

This study aimed to determine the efficacy of different Leucovorin regimens to reduce oral mucositis in children with acute lymphoblastic leukemia after high-dose Methotrexate (HD-MTX).

METHODS

Twelve articles were included in a systematic literature review. Articles were categorized into low/medium/high risk of bias.

RESULTS

As no randomized controlled trial assessing the effect of Leucovorin has been performed, the efficacy of Leucovorin to reduce oral mucositis remains unknown. Leucovorin was initiated at 24, 36 or 42 h after HD-MTX at a dose of 15 or 30 mg/m. No meta-analysis could be performed as treatment regimens differed. When comparing studies with similar HD-MTX doses, we observed lower oral mucositis rates in regimens with higher cumulative doses of Leucovorin and early initiation of Leucovorin after MTX.

CONCLUSION

Even though future studies are necessary, higher cumulative Leucovorin doses and early initiation of Leucovorin after start of MTX seem to reduce oral mucositis.

摘要

介绍

本研究旨在确定不同亚叶酸钙方案对接受大剂量甲氨蝶呤(HD-MTX)治疗的急性淋巴细胞白血病患儿口腔黏膜炎的疗效。

方法

系统文献回顾纳入了 12 篇文章。文章分为低/中/高偏倚风险。

结果

由于尚未进行评估亚叶酸钙疗效的随机对照试验,因此尚不清楚亚叶酸钙是否能减少口腔黏膜炎。亚叶酸钙在 HD-MTX 后 24、36 或 42 小时开始使用,剂量为 15 或 30mg/m2。由于治疗方案不同,无法进行荟萃分析。当比较具有相似 HD-MTX 剂量的研究时,我们观察到在亚叶酸钙累积剂量更高和在 MTX 开始后更早开始使用亚叶酸钙的方案中,口腔黏膜炎发生率较低。

结论

尽管需要进一步研究,但更高的亚叶酸钙累积剂量和在 MTX 开始后尽早开始使用亚叶酸钙似乎可以减少口腔黏膜炎。

相似文献

1
The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.亚叶酸钙解救疗法对儿童急性淋巴细胞白血病治疗中氨甲喋呤诱导的口腔黏膜炎的作用:系统评价。
Crit Rev Oncol Hematol. 2019 Oct;142:1-8. doi: 10.1016/j.critrevonc.2019.07.003. Epub 2019 Jul 9.
2
Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.小儿急性淋巴细胞白血病中口腔黏膜炎与大剂量甲氨蝶呤治疗的关系
Int J Clin Pharmacol Ther. 2008 Nov;46(11):584-90. doi: 10.5414/cpp46584.
3
A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.维生素 D 水平下降与儿童急性淋巴细胞白血病患者甲氨蝶呤诱导的口腔黏膜炎有关。
Support Care Cancer. 2019 Jan;27(1):183-190. doi: 10.1007/s00520-018-4312-0. Epub 2018 Jun 19.
4
High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.儿童急性淋巴细胞白血病的大剂量甲氨蝶呤治疗:血清甲氨蝶呤浓度与肌酐清除率之间无相关性。
Pediatr Blood Cancer. 2004 Jul;43(1):17-22. doi: 10.1002/pbc.20032.
5
Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.全球甲基化与儿童急性淋巴细胞白血病患者甲氨蝶呤诱导的口腔黏膜炎的关系。
PLoS One. 2018 Jul 9;13(7):e0199574. doi: 10.1371/journal.pone.0199574. eCollection 2018.
6
The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia.方案 M 治疗儿童急性淋巴细胞白血病期间红细胞叶酸和甲氨蝶呤水平的评估。
BMC Cancer. 2020 Sep 30;20(1):940. doi: 10.1186/s12885-020-07422-y.
7
Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.癌症患儿血浆甲氨蝶呤、中性粒细胞减少、肝功能障碍、恶心/呕吐及口腔黏膜炎之间的关联。
Eur J Cancer Care (Engl). 2008 May;17(3):306-11. doi: 10.1111/j.1365-2354.2007.00843.x.
8
Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: relation to oral mucositis.对接受大剂量巩固治疗的急性淋巴细胞白血病患儿唾液中甲氨蝶呤和7-羟基甲氨蝶呤的监测:与口腔黏膜炎的关系
Anticancer Drugs. 1997 Feb;8(2):119-24. doi: 10.1097/00001813-199702000-00003.
9
Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.儿童急性淋巴细胞白血病大剂量甲氨蝶呤和亚叶酸钙解救治疗期间细胞内叶酸代谢的变化。
PLoS One. 2019 Sep 17;14(9):e0221591. doi: 10.1371/journal.pone.0221591. eCollection 2019.
10
The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.胸苷酸合成酶(TYMS)基因多态性在急性淋巴细胞白血病患儿甲氨蝶呤诱导的口腔黏膜炎中的作用
Pharmacogenet Genomics. 2018 Oct;28(10):223-229. doi: 10.1097/FPC.0000000000000352.

引用本文的文献

1
Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤中与高剂量甲氨蝶呤诱导毒性相关的危险因素。
Front Pharmacol. 2025 Aug 4;16:1561818. doi: 10.3389/fphar.2025.1561818. eCollection 2025.
2
SNP's use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic.单核苷酸多态性作为乳腺癌潜在化学毒性分层工具的应用:从实验室到临床
Funct Integr Genomics. 2025 Apr 22;25(1):93. doi: 10.1007/s10142-025-01602-4.
3
Dose adjustment strategy for high-dose methotrexate-induced toxicities in pediatric acute lymphoblastic leukemia: based on population PK analysis and exposure-toxicity relationship.
儿童急性淋巴细胞白血病中高剂量甲氨蝶呤诱导毒性的剂量调整策略:基于群体药代动力学分析和暴露-毒性关系
Cancer Chemother Pharmacol. 2025 Feb 15;95(1):33. doi: 10.1007/s00280-025-04750-3.
4
Impact of MTHFD2 Expression in Bladder/Breast Cancer and Screening of Its Potential Inhibitor.MTHFD2表达在膀胱癌/乳腺癌中的作用及其潜在抑制剂的筛选
ACS Omega. 2024 Oct 23;9(44):44193-44202. doi: 10.1021/acsomega.4c03599. eCollection 2024 Nov 5.
5
Clinical Risk Factors for High-Dose Methotrexate-Induced Oral Mucositis Following Individualized Dosing.个体化剂量后大剂量甲氨蝶呤致口腔黏膜炎的临床危险因素。
Cancer Med. 2024 Nov;13(21):e70351. doi: 10.1002/cam4.70351.
6
Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis.比较造血细胞移植中,甲氨蝶呤作为移植物抗宿主病预防药物与其他免疫抑制预防药物相关的严重口腔黏膜炎风险:一项系统评价和荟萃分析。
Support Care Cancer. 2024 Jul 17;32(8):519. doi: 10.1007/s00520-024-08722-w.
7
Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning.三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病的临床疗效及安全性
Support Care Cancer. 2023 Aug 15;31(9):521. doi: 10.1007/s00520-023-07989-9.
8
Recommendations for Nutritional Supplementation in Pediatric Oncology: A Compilation of the Facts.儿童肿瘤学营养补充建议:事实汇编
Nutrients. 2023 Jul 21;15(14):3239. doi: 10.3390/nu15143239.
9
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.诱导治疗期间鞘内给予两次额外剂量甲氨蝶呤对急性淋巴细胞白血病患儿严重感染性毒性的影响。
Haematologica. 2023 Dec 1;108(12):3278-3286. doi: 10.3324/haematol.2022.281788.
10
Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties.抗癌药物:提高稳定性、药代动力学和药效学特性的最新策略。
Molecules. 2022 Aug 25;27(17):5436. doi: 10.3390/molecules27175436.